Your browser doesn't support javascript.
loading
Inferring disease course from differential exon usage in the wide titinopathy spectrum.
Di Feo, Maria Francesca; Oghabian, Ali; Nippala, Ella; Gautel, Mathias; Jungbluth, Heinz; Forzano, Francesca; Malfatti, Edoardo; Castiglioni, Claudia; Krey, Ilona; Gomez Andres, David; Brady, Angela F; Iascone, Maria; Cereda, Anna; Pezzani, Lidia; Natera De Benito, Daniel; Nascimiento Osorio, Andres; Estévez Arias, Berta; Kurbatov, Sergei A; Attie-Bitach, Tania; Nampoothiri, Sheela; Ryan, Erin; Morrow, Michelle; Gorokhova, Svetlana; Chabrol, Brigitte; Sinisalo, Juha; Tolppanen, Heli; Tolva, Johanna; Munell, Francina; Camacho Soriano, Jessica; Sanchez Duran, Maria Angeles; Johari, Mridul; Tajsharghi, Homa; Hackman, Peter; Udd, Bjarne; Savarese, Marco.
Afiliación
  • Di Feo MF; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Oghabian A; Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
  • Nippala E; Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
  • Gautel M; Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
  • Jungbluth H; Randall Division of Cell and Molecular Biophysics and Cardiovascular Division, King's College London BHF Centre of Research Excellence, London, UK.
  • Forzano F; Randall Division of Cell and Molecular Biophysics and Cardiovascular Division, King's College London BHF Centre of Research Excellence, London, UK.
  • Malfatti E; Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's and St Thomas' Hospitals NHS Trust, London, UK.
  • Castiglioni C; Clinical Genetics Department, Guy's and St Thomas NHS Foundation Trust, London, SE1 9RT, UK.
  • Krey I; Université Paris Est Créteil, INSERM, U955, IMRB, and Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital, Créteil, France.
  • Gomez Andres D; Clinica MEDS, Santiago de Chile, Chile.
  • Brady AF; Institute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig, 4275, Germany.
  • Iascone M; Child Neurology Unit. Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Cereda A; North West Thames Regional Service, Northwick Park and St. Mark's Hospitals, Harrow, London, UK.
  • Pezzani L; Medical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Natera De Benito D; Clinical Genetics Service, Pediatria 1-ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Nascimiento Osorio A; Clinical Genetics Service, Pediatria 1-ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Estévez Arias B; Neuropaediatrics Department, Hospital Sant Joan De Déu, Institut De Recerca Sant Joan De Déu, Barcelona, 08950, Spain.
  • Kurbatov SA; Neuropaediatrics Department, Hospital Sant Joan De Déu, Institut De Recerca Sant Joan De Déu, Barcelona, 08950, Spain.
  • Attie-Bitach T; Neuromuscular Unit, Department of Neurology, Hospital Sant Joan De Déu, Barcelona, Spain.
  • Nampoothiri S; Voronezh NN Burdenko State Medical University, Voronezh, 394036, Russia.
  • Ryan E; Saratov State Medical University, Saratov, 410012, Russia.
  • Morrow M; Unité D'embryofoetopathologie, Service D'histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, Paris, France.
  • Gorokhova S; Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India.
  • Chabrol B; GeneDx, Gaithersburg, Maryland, USA.
  • Sinisalo J; GeneDx, Gaithersburg, Maryland, USA.
  • Tolppanen H; Marseille Medical Genetics, Aix Marseille Université, Faculté Des Sciences Médicales Et Paramédicales, Marseille, France.
  • Tolva J; Reference Center for Inherited Metabolic Diseases, Marseille University Hospital, Marseille, France.
  • Munell F; Helsinki University Central Hospital, Helsinki, Finland.
  • Camacho Soriano J; Helsinki University Central Hospital, Helsinki, Finland.
  • Sanchez Duran MA; Transplantation Laboratory, Department of Pathology, University of Helsinki, Helsinki, Finland.
  • Johari M; Unitat De Malalties Neuromusculars Pediàtriques, Hospital Universitari Vall D'Hebron, Barcelona, Spain.
  • Tajsharghi H; Histology Department, Vall D'Hebron University Hospital, Barcelona, Spain.
  • Hackman P; Maternal Fetal Medicine Unit, Department of Obstetrics, Universitat Autònoma de Barcelona, Hospital Vall D'Hebron, Barcelona, Spain.
  • Udd B; Folkhälsan Research Center, Helsinki, Uusimaa, Finland.
  • Savarese M; Harry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Western Australia, Australia.
Article en En | MEDLINE | ID: mdl-39198997
ABSTRACT

OBJECTIVE:

Biallelic titin truncating variants (TTNtv) have been associated with a wide phenotypic spectrum, ranging from complex prenatal muscle diseases with dysmorphic features to adult-onset limb-girdle muscular dystrophy, with or without cardiac involvement. Given the size and complexity of TTN, reaching an unequivocal molecular diagnosis and precise disease prognosis remains challenging.

METHODS:

In this case series, 12 unpublished cases and one already published case with biallelic TTNtv were collected from multiple international medical centers between November 2022 and September 2023. TTN mutations were detected through exome or genome sequencing. Information about familial and personal clinical history was collected in a standardized form. RNA-sequencing and analysis of TTN exon usage were performed on an internal sample cohort including postnatal skeletal muscles, fetal skeletal muscles, postnatal heart muscles, and fetal heart muscles. In addition, publicly available RNA-sequencing data was retrieved from ENCODE.

RESULTS:

We generated new RNA-seq data on TTN exons and identified genotype-phenotype correlations with prognostic implications for each titinopathy patient (whether worsening or improving in prenatal and postnatal life) using percentage spliced in (PSI) data for the involved exons. Interestingly, thanks to exon usage, we were also able to rule out a titinopathy diagnosis in one prenatal case.

INTERPRETATION:

This study demonstrates that exon usage provides valuable insights for a more exhaustive clinical interpretation of TTNtv; additionally, it may serve as a model for implementing personalized medicine in many other genetic diseases, since most genes undergo alternative splicing.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Clin Transl Neurol Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Clin Transl Neurol Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos